As osteogenic differentiation of MSCs has also been proven to be initiated by the non-canonical Wnt pathway, some investigations have illustrated that MM cells are capable of blocking the non-canonical Wnt signaling pathway by inhibiting the expression of the Wnt5a receptor, Ror2, in human osteoblastic progenitors [33]. The gene discussed is ROR2; the disease is Miyoshi myopathy.